A pill to prevent migraine? Discovery of migraine gene could put it on the horizon

June 1, 2011

The discovery of a gene for migraine holds great promise in the quest for new approaches -- possibly even a pill -- for preventing the disease, says a panel of experts presenting data at the annual scientific meeting of the American Headache Society. So far, there is no therapy that prevents an attack.

Guy A. Rouleau, MD, whose Canadian and British research team was first to sequence the gene for migraine last fall, says for the first time since the of the triptans in the 1980s, seeking to develop new migraine therapies are excited about the possibility of preventive drugs for migraine. Triptans act by constricting blood vessels in the brain which in turn inhibit receptors which can block migraine in some patients. They are e not considered preventative therapies.

"We may be moving toward developing about a pill that would block the brain's pain channel that reacts to stimulation and causes pain in migraine," says Dr. Rouleau. 'Sequencing the gene not only allows us to understand the disease – it also opens understanding of the pain pathways that trigger migraine pain." Dr. Rouleau is director of the CHU Sainte-Justine Research Center and Full Professor in the Department of Medicine of the Université de Montreal.

"For the first time in decades, I have seen great interest by the research community," he said, "including the private pharmaceutical industry in developing preventive migraine therapies."

Dr. Rouleau is part of a panel on "Migraine and Genetics" devoted to discussing the implications of sequencing the gene for migraine. The session will be at 9:45 am, Friday, June3. More than 500 migraine specialists in clinical practice and research from around the world attend the annual session which this year focuses on "New Discoveries in Headache Medicine," chaired by R. Allan Purdy, MD, of Dalhousie University in Halifax, Nova Scotia.

"The discovery of a gene for migraine with aura last fall was important because it confirms the longstanding observation that migraine "runs" in some families," Dr. Purdy said. "The presence of genetic factors in a common form of holds promise for developing an effective treatment."

Explore further: Many migraine sufferers can predict their migraine attack

Related Stories

Many migraine sufferers can predict their migraine attack

June 1, 2011
As many as one-third of sufferers of migraine with aura experience forewarning symptoms even the day before an attack that might create an opportunity for intervention and prevention. Later during the actual migraine episode ...

Recommended for you

Addressing superbug resistance with phage therapy

August 16, 2017
International research involving a Monash biologist shows that bacteriophage therapy – a process whereby bacterial viruses attack and destroy specific strains of bacteria - can be used successfully to treat systemic, multidrug ...

Can previous exposure to west Nile alter the course of Zika?

August 15, 2017
West Nile virus is no stranger to the U.S.-Mexico border; thousands of people in the region have contracted the mosquito-borne virus in the past. But could this previous exposure affect how intensely Zika sickens someone ...

Compounds in desert creosote bush could treat giardia and 'brain-eating' amoeba infections

August 15, 2017
Researchers at Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego and the University of Colorado Anschutz Medical Campus have found that compounds produced by the creosote bush, a ...

New malaria analysis method reveals disease severity in minutes

August 11, 2017
Left untreated, malaria can progress from being mild to severe—and potentially fatal—in 24 hours. So researchers at the University of British Columbia developed a method to quickly and sensitively assess the progression ...

Drug trial shows promise for deadly neurological disorder

August 10, 2017
Results of a small clinical trial show promise for treating a rare neurodegenerative condition that typically kills those afflicted before they reach age 20. The disease, called Niemann-Pick type C (NPC), causes cholesterol ...

Test uses nanotechnology to quickly diagnose Zika virus

August 10, 2017
Washington University in St. Louis researchers have developed a test that quickly detects the presence of Zika virus in blood.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.